Controlled study of ONO-2506 [arundic acid] in patients with acute ischemic stroke.
Phase of Trial: Phase II/III
Latest Information Update: 06 Jun 2016
At a glance
- Drugs Arundic acid (Primary)
- Indications Stroke
- Focus Adverse reactions; Therapeutic Use
- Sponsors Ono Pharmaceutical
- 11 Dec 2008 Status changed from active, no longer recruiting to completed, as reported in ClinicalTrials.gov record.
- 14 Jun 2008 Status changed from recruiting to in progress.
- 14 Jun 2008 The expected completion date for this trial is now 1 Dec 2008.